发明授权
US5610013A Method for diagnosing a disorder by determining expression of gage tumor
rejection antigen precursors
失效
通过测定计量肿瘤排斥抗原前体的表达来诊断病症的方法
- 专利标题: Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors
- 专利标题(中): 通过测定计量肿瘤排斥抗原前体的表达来诊断病症的方法
-
申请号: US250162申请日: 1994-05-27
-
公开(公告)号: US5610013A公开(公告)日: 1997-03-11
- 发明人: Benoit Van den Eynde , Thierry Boon-Falleur
- 申请人: Benoit Van den Eynde , Thierry Boon-Falleur
- 申请人地址: NY New York
- 专利权人: Ludwig Institute for Cancer Research
- 当前专利权人: Ludwig Institute for Cancer Research
- 当前专利权人地址: NY New York
- 主分类号: G01N33/566
- IPC分类号: G01N33/566 ; A61K35/12 ; A61K38/00 ; A61K48/00 ; A61K49/00 ; A61P35/00 ; C07H21/04 ; C07K14/47 ; C07K14/74 ; C12N5/10 ; C12N15/09 ; C12P21/02 ; C12Q1/68 ; G01N33/574 ; C07H19/00 ; C12N1/20 ; C12N5/00
摘要:
A new family of tumor rejection antigen precursors, and the nucleic acid molecules which code for them, are disclosed. These tumor rejection antigen precursors are referred to as GAGE tumor rejection antigen precursors, and the nucleic acid molecules which code for them are referred to as GAGE coding molecules. Various diagnostic and therapeutic uses of the coding sequences and the tumor rejection antigens, and their precursor molecules are described.
公开/授权文献
- US6101335A Zoom lens barrel assembly for a camera 公开/授权日:2000-08-08
信息查询
IPC分类: